| Protein-folding
Diseases and Chaperone Biology
|
We have developed yeast models of protein folding diseases and used them to investigate mechanisms of cytotoxicity and to screen for novel therapeutic targets.
Strong evidence links the misfolding of alpha-synuclein (a-syn ) to Parkinson’s Disease (PD). Cellular toxicity depends on the level of a-syn expression and is associated with cytoplasmic inclusions. Our yeast a-syn overexpression model recapitulates many features of a-syn-related pathology, including the inhibition of phospholipase D, the production of reactive oxygen species, and problems in vesicle trafficking. The earliest defect following a-syn induction in yeast was a block in vesicle trafficking from the endoplasmic reticulum (ER) to the Golgi. To identify relevant biochemical pathways and targets we screened an expression library for genetic enhancers and suppressors of a-syn toxicity. The largest class of toxicity modifiers includes proteins functioning at this same trafficking step, including the Rab GTPase Ypt1p, which is also associated with cytoplasmic a-syn inclusions. Elevated expression of Rab1, the mammalian YPT1 homolog, protects against a-syn-induced dopaminergic neuron loss in whole-animal models of PD, and in cultures of rat midbrain, demonstrating the relevance of results obtained in yeast to mammalian neurons.
MIT TechTV Documentary about
our lab's yeast
a-synuclein model:
(4
minutes, 53 seconds)

Left: yeast cells expressing one copy of fluorescent green-tagged human alpha-synuclein; Right: yeast cells expressing two copies. Overexpression of alpha-synuclein causes formation of protein foci and kills the cells.
We have expanded our efforts to screen for toxicity enhancers and suppressors in a yeast Huntington’s Disease model expressing human huntingtin exon I. Our work presents a paradigm for how toxicity is the result of the interaction of particular disease-associated proteins with eukaryotic cell biology and not merely a non-specific response to protein misfolding. The specific pathways elucidated by our yeast models provide new targets for therapeutic intervention.
Lindquist discusses her Science paper, "{alpha}-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson’s Models," (Abstract) (Reprint) on Morning Edition and Science Friday
Selected
Publications on Protein-folding Diseases
Su LJ, Auluck PK, Outeiro TF, Yeger-Lotem E, Kritzer JA, Tardiff DF, Strathearn KE, Liu F,Cao S, Hamamichi S, Hill KJ, Caldwell KA, Bell GW, Fraenkel E, Cooper AA, Caldwell GA, Michael McCaffery JM, Rochet J-C, Lindquist S, 2009. Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson disease models Dis Model Mech in press.
Kritzer JA, Hamamichi S, McCaffery JM, Santagata S, Naumann TA, Caldwell KA, Caldwell GA, Lindquist S, 2009. Rapid Selection of Cyclic Peptides that Reduce Alpha-Synuclein Toxicity in Yeast and Animal Models. Nat Chem Biol 5(9): 655-63. PMCID: 2729362
Yeger-Lotem E, Riva L, Su LJ, Gitler AD, Cashikar A, King OD, Auluck PK, Geddie ML, Valastyan JS, Karger DR, Lindquist S, Fraenkel E, 2009. Bridging the gap between high-throughput genetic and transcriptional data reveals cellular pathways responding to alpha-synuclein toxicity. Nat Genet, 41(3): 316-23. [PDF 3.1 MB]
Gitler AD, Chesi A, Geddie ML, Strathearn
KE, Hamamichi S, Hill KJ, Caldwell KA, Caldwell GA,
Cooper AA, Rochet J-C, Lindquist S, 2009. ?-Synuclein is part of a diverse and
highly conserved interaction network that includes PARK9 and manganese toxicity.
Nat Genet, 41(3): 308-15. [PDF
2.5 MB]
Rappley I, Gitler AD, Selvy PE, LaVoie MJ, Levy BD, Brown HA, Lindquist S, Selkoe DJ, 2009. Evidence that alpha-synuclein does not inhibit phospholipase D. Biochemistry, 48(5): 1077-83. [PDF 332 KB]
Duennwald ML, Lindquist S, 2008. Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. Genes Dev 22(23): 3308-19. [PDF 1 MB]
Lo Bianco C, Shorter J, Régulier E, Lashuel H, Iwatsubo T, Lindquist S, Aebischer P, 2008. Hsp104 Antagonizes a-Synuclein Aggregation and Reduces Dopaminergic Degeneration in a Rat Model of Parkinson’s Disease. J Clin Invest, 118(9): 3087-97. [PDF 1.43 MB]
Johnson BS, McCaffery JM, Lindquist S, Gitler AD, 2008. A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. PNAS, 105(17): 6439-6444. [PDF 627 KB]
Fleming J, Outiero TF, Slack M, Lindquist SL and Bulawa CE, 2008. Detection of compounds that rescue rab1-synuclein toxicity. Methods Enzymol, 439: 339-51. [PDF 181 KB]
Gitler AD, Bevis BJ, Shorter J, Strathearn KE, Hamamichi S, Su LJ, Caldwell KA, Caldwell GA, Rochet JC, McCaffery JM, Barlowe C and Lindquist S, 2008. The Parkinson’s Disease Protein Alpha-Synuclein Disrupts Cellular Rab Homeostasis. Proc Natl Acad Sci USA 105(1): 145-50. [PDF 832 KB]
Alberti S, Gitler AD and Lindquist S, 2007. A suite of Gateway™ cloning vectors for high-throughput genetic analysis in Saccharomyces cerevisiae. Yeast 24(10):913-19. [PDF 972 KB]
Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu K, Xu K, Strathearn KE, Liu F, Cao S, Caldwell KA, Caldwell GA, Marsischky G, Kolodner RD, LaBaer J, Rochet J-C, Bonini NM and Lindquist S, 2006. alpha-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson’s Models. Science 313(5785): 324-8. [PDF Link]
Duennwald ML, Jagadish S, Muchowski PJ and Lindquist S, 2006. Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc Natl Acad Sci USA 103(29): 11045-50. [PDF 1.29 MB]
Duennwald ML, Jagadish S, Giorgini F, Muchowski PJ and Lindquist S, 2006. A network of protein interactions determines polyglutamine toxicity. Proc Natl Acad Sci USA103(29): 11051-56. [PDF 1.46 MB]
Outeiro TF and Lindquist S, 2003. Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology. Science 302:1772-75. [PDF Link]
Krobitsch S and Lindquist S, 2000. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci USA 97: 1589-94. [PDF 493 KB]
To obtain reagents described in Cooper et al. (2006) or Outeiro and Lindquist (2003), please download and fill out an MTA from the Request Materials page.
Chaperone
Biology and Protein Disaggregation
|
Heat-shock proteins (Hsps)
are molecular chaperones that are induced when organisms are exposed
to high temperatures and other stresses. These stresses cause proteins
to unfold
and potentially
aggregate,
thereby creating a protein-folding crisis in the cell. Hsp chaperones
help the cell cope with this crisis by binding different types
of folding intermediates and interacting with them in different ways.
One, Hsp104, has a unique ability to promote the disaggregation of
aggregated proteins. This biochemical function is in keeping with its
biological function: Hsp104 is not required for normal growth but is
required for survival under extreme stress. Homologues of Hsp104 have
been found in other fungi, bacteria and plants and appear to function
in
a similar way.
Hsp104 is a member of the important AAA family of proteins. AAA-proteins function
to remodel other cellular proteins and thus affect a multitude of biological
processes. Their power to remodel substrates lies in their capacity to couple
substrate binding to conformational change. Hsp104s ability to remodel
protein structures also plays a critical role in protein conformation-based
inheritance. In order to understand how Hsp104 functions in this capacity,
we are employing a variety of biochemical and genetic approaches.

Deconstruction of Sup35 prion fibers by Hsp104
Selected Publications on Chaperone Biology
Sénéchal P, Arseneault G, Leroux A, Susan Lindquist S, Rokeach LA, 2009. The Schizosaccharomyces pombe Hsp104 disaggregase is unable to propagate the [PSI+] prion. PLoS ONE 4(9): e6939. PMCID: 2736384
Wendler P, Shorter J, Snead D, Plisson C, Clare DK, Lindquist S, Saibil HR, 2009. Motor mechanism for protein threading through Hsp104. Mol Cell 34(1): 81-92. PMCID: PMC2689388
Beauregard PB, Guérin R, Turcotte C, Lindquist S, Rokeach LA, 2009. A nucleolar protein allows viability in the absence of the essential ER chaperone calnexin. J Cell Sci 122: 1342-1351.
Shorter J, Lindquist S, 2008. Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prions. EMBO J 27(20): 2712-24. [PDF 2.1 MB]
Sadlish H, Rampelt H, Shorter J, Wegrzyn RD, Andreasson C, Lindquist S, and Bukau B, 2008. Hsp110 Chaperones Regulate Prion Formation and Propagation in S. cerevisiaeby Two Discrete Activities. PLoS ONE, 3(3): e1763. [PDF 737 KB]
Wang H, Duennwald ML, Roberts BE, Rozeboom LM, Zhang YL, Steele AD, Krishnan R, Su LJ, Griffin D, Mukhopadhyay S, Hennessy EJ, Weigele P, Blanchard BJ, King J, Deniz AA, Buchwald SL, Ingram VM, Lindquist S, Shorter J, 2008. Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs. Proc Natl Acad Sci USA 105(20): 7159-64. [PDF 1.37 MB]
|
| Doyle
SM, Shorter J, Zolkiewski M, Hoskins JR, Lindquist S, Wickner S, 2007.
Asymmetric deceleration of ClpB or Hsp104 ATPase activity unleashes protein-
remodeling activity. Nat. Struct. Mol. Biol. 14(2): 114-22. [PDF
480 KB]
|
Wendler P, Shorter J, Plisson C, Cashikar AG, Lindquist S Saibil HR, 2007. Atypical AAA+ subunit packing creates an expanded cavity for disaggregation by the protein-remodeling factor Hsp104. Cell 131(7): 1366-77. [PDF 1.7 MB]
Shorter J, Lindquist S, 2006. Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities. Mol Cell 23(3): 425-38. [PDF 1.2MB]
Cashikar AG, Duennwald M, Lindquist SL, 2005. A chaperone pathway in protein disaggregation: Hsp26 alters the nature of protein aggregates to facilitate reactivation by hsp104. J Biol Chem 280:23869-75. [PDF 1.2MB]
Shorter J, Lindquist S, 2004. Hsp104
Catalyzes Formation and Elimination of Self-Replicating Sup35 Prion Conformers.
Science 304:1793-97. [PD
FLink]
Hattendorf DA, Lindquist S, 2002. Cooperative kinetics of both Hsp104 ATPase
domains and interdomain communication revealed by AAA sensor-1 mutants. EMBO
J21: 12-21.[PDF
344 KB]
Schirmer EC, Ware DM, Queitsch C, Kowal AS, Lindquist S, 2001. Subunit interactions
influence the biochemical and biological properties of Hsp104. Proc
Natl Acad Sci USA 98: 914-19.
[PDF
236 KB]
Queitsch C, Hong S-W, Vierling E, Lindquist S, 2000. Hsp101 plays a crucial
role in thermotolerance in Arabidopsis. The Plant Cell 12: 479-92.[PDF
656 KB]
Glover JR, Lindquist S, 1998. Hsp104, Hsp70 and Hsp40: a novel chaperone system
that rescues previously aggregated proteins. Cell 94:73-82.
Lindquist S, 1981. Regulation of protein synthesis during heat shock. Nature 293: 311-14. [PDF 852 KB]
McKenzie SL, Henikoff S, Meselson M, 1975. Localization of RNA from heat-induced polysomes at puff sites in Drosophila melanogaster. Proc Natl Acad Sci USA 72: 1117-11. [PDF 2.5 MB]
Who's Working on Protein-folding Diseases and Chaperone Biology
Ambar
Mehta
Brooke
Bevis
Chee-Yeun
Chung
Chris
Pacheco
Dan
Tardiff
Dan
Termine
Gabriela
Caraveo
Julie
Valastyan
Kent
Matlack
Lera
Baru
Melissa
Geddie
Pavan
Auluck
Richard Manfready
Vik
Khurana
Yelena
Freyzon
Collaborators
Patrick Aebischer, Swiss Federal Institute of Technology, Lausanne
Guy and Kim Caldwell, University of Alabama
Marie-Francoise Chesselet, UCLA
Antony Cooper, Garvan Institute of Medical Research, Sydney, Australia
Ernest Fraenkel, M.I.T.
Aaron Gitler, University of Pennsylvania
Rudolf Jaenisch, Whitehead Institute
Joshua Kritzer, Tufts University
Paul Muchowski, UCSF
Richard H. Myers, Boston University
Chris Rochet, Purdue University
Luis Rokeach, University of Montreal
Helen Saibil, Birkbeck College, London
Jim Shorter, University of Pennsylvania